Euretos

Euretos provides AI-driven contract research services and cloud access to the Euretos AI platform for preclinical discovery and clinical validation of targets, biomarkers, and indications. Our applications and services provide researchers with fundamental and novel insights into the systems biology and molecular mechanisms driving phenotypes, disease pathology, toxicity, and drug response.Euretos semantically integrates over 275 public life science data and text sources using machine reading to offer the largest knowledge base, where multi-omics data are linked to literature, patents, experimental, and clinical evidence.State-of-the-art machine and deep learning algorithms for cell type deconvolution, co-expression prediction, and target perturbation analysis leverage this unique knowledge base to create highly insightful molecular disease models.These unique assets enable (preclinical) researchers to adopt a translational systems biology approach, linking multi-omics interactions to downstream pathways, phenotypes, and disease pathology through cell type involvement.Euretos takes a unique approach as we are the only AI provider in the drug development space: a pure product and service provider without developing our own pipeline; we use machine reading for data integration, significantly enhancing data quality; we develop end-user cloud applications for biological researchers (i.e., non-data scientists), impacting all levels of R&D organizations; and we place special emphasis on the biological effects of diseases and drug treatments at the systems biology and molecular levels.